These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22538426)

  • 21. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
    Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis.
    Hsu SM; Yang CH; Shen FH; Chen SH; Lin CJ; Shieh CC
    Mediators Inflamm; 2015; 2015():847373. PubMed ID: 25653480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Profile of Cationic Amino Acid Transporters in Rats with Endotoxin-Induced Uveitis.
    Hsu YR; Chang SW; Yang CH; Lee YA; Kao TY
    Mediators Inflamm; 2016; 2016():6586857. PubMed ID: 27413255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
    Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM
    Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
    Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
    Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
    Medeiros R; Rodrigues GB; Figueiredo CP; Rodrigues EB; Grumman A; Menezes-de-Lima O; Passos GF; Calixto JB
    Mol Pharmacol; 2008 Jul; 74(1):154-61. PubMed ID: 18413658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.
    Chen FT; Yang CM; Yang CH
    PLoS One; 2013; 8(5):e64262. PubMed ID: 23691186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of artesunate on endotoxin-induced uveitis in rats.
    Wang XQ; Liu HL; Wang GB; Wu PF; Yan T; Xie J; Tang Y; Sun LK; Li C
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):916-9. PubMed ID: 20881305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats.
    Jacquemin E; de Kozak Y; Thillaye B; Courtois Y; Goureau O
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1187-96. PubMed ID: 8631633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gold nanoparticles on endotoxin-induced uveitis in rats.
    Pereira DV; Petronilho F; Pereira HR; Vuolo F; Mina F; Possato JC; Vitto MF; de Souza DR; da Silva L; da Silva Paula MM; de Souza CT; Dal-Pizzol F
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8036-41. PubMed ID: 23150627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
    Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
    Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
    Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
    Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.
    Poulaki V; Iliaki E; Mitsiades N; Mitsiades CS; Paulus YN; Bula DV; Gragoudas ES; Miller JW
    FASEB J; 2007 Jul; 21(9):2113-23. PubMed ID: 17400913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
    Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
    Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipocalin 2 Suppresses Ocular Inflammation by Inhibiting the Activation of NF-κβ Pathway in Endotoxin-Induced Uveitis.
    Tang W; Ma J; Gu R; Ding X; Lei B; Wang X; Zhuang H; Xu G
    Cell Physiol Biochem; 2018; 46(1):375-388. PubMed ID: 29590655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100A9-positive granulocytes and monocytes in lipopolysaccharide-induced anterior ocular inflammation.
    Chi ZL; Hayasaka Y; Zhang XY; Cui HS; Hayasaka S
    Exp Eye Res; 2007 Feb; 84(2):254-65. PubMed ID: 17101129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylbritannilactone suppresses lipopolysaccharide-induced vascular smooth muscle cell inflammatory response.
    Liu YP; Wen JK; Zheng B; Zhang DQ; Han M
    Eur J Pharmacol; 2007 Dec; 577(1-3):28-34. PubMed ID: 17915214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
    An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
    Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
    Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.